Shockwave Medical's CMO discusses the C2 Aero launch, why the company is defining what qualifies as true IVL, and J&J's R&D ...
Medical Device Network on MSN
Cagent Vascular raises $41m for dual-modality IVL platform advancement
Cagent will use the funds to complete a pivotal trial of its Serranator SONIC IVL system and support commercial necessitates for the platform.
J&J has launched its Shockwave C2 Aero Coronary IVL Catheter globally, marking an advancement in the treatment of calcified ...
Medical Device Network on MSN
J&J launches Shockwave C2 Aero catheter for calcified CAD treatment
The Shockwave C2 Aero is designed to streamline treatment strategies by improving flexibility for physicians.
SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
For decades, doctors have struggled with the same stubborn problem: arteries hardened by calcium are too rigid for standard ...
Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...
SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results